3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
87
Carcinoma, Non-Small-Cell Lung
78
Multiple Myeloma
72
Prostatic Neoplasms
66
Neoplasms
47
Lymphoma
43
Leukemia, Myeloid, Acute
42
Melanoma
38
Neoplasm Metastasis
37
Lymphoma, Non-Hodgkin
33
Ovarian Neoplasms
32
Lung Neoplasms
32
Squamous Cell Carcinoma of Head and Neck
31
Hematologic Neoplasms
29
Leukemia, Lymphocytic, Chronic, B-Cell
28
Colorectal Neoplasms
26
Triple Negative Breast Neoplasms
23
Hodgkin Disease
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Myelodysplastic Syndromes
21
Sarcoma
20
Fallopian Tube Neoplasms
20
Pancreatic Neoplasms
19
Carcinoma, Renal Cell
19
Lymphoma, Follicular
17
Leukemia
17
Head and Neck Neoplasms
17
Glioma
17
Urinary Bladder Neoplasms
16
Recurrence
16
Interventions
Pemetrexed
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
CP protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Non Small Cell Lung Carcinoma NSCLC
×
90 days
×
Clear all
NCT02542293
2026-05-01
NEPTUNE
AstraZeneca
Phase 3
Active not recruiting
953 enrolled
29 charts